echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Eur Heart J: Clinical manifestations, course and outcome of COVID-19 hospitalized patients with previous heart disease

    Eur Heart J: Clinical manifestations, course and outcome of COVID-19 hospitalized patients with previous heart disease

    • Last Update: 2021-11-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Since December 2019, COVID-19 has spread rapidly around the world.
    As of September 19, 2021, there have been more than 225 million confirmed cases and nearly 4.
    7 million deaths
    .


    Patients with heart disease are considered to be at high risk of adverse outcomes after being hospitalized for COVID-19


    COVID-19

    Recently, the heart blood vessels magazine field authority Eur Heart published a research article on J, the purpose of this study was to evaluate the association between the heterogeneity of the various subtypes of heart disease in patients with in-hospital mortality
    .

    Heart blood vessels

    The researchers used data from the CAPACITY-COVID Registry and the LEOSS study, and fitted a multivariate Poisson regression model to assess the association between different types of heart disease and hospital mortality
    .

    The study included 16511 COVID-19 patients (21.
    1% of the patients were 66-75 years old; 40.
    2% were women), and 31.
    5% of the subjects had a history of heart disease
    .


    Patients with heart disease are older, mainly male, and usually have other comorbidities compared with patients without heart disease


    diagnosis

    It can be seen that there is considerable heterogeneity in the strength of the association between heart disease subtypes and hospital mortality
    .


    Among all heart disease patients, patients with heart failure are at the greatest risk of death due to COVID-19 hospitalization


    There is considerable heterogeneity in the strength of the association between heart disease subtypes and hospital mortality


    Original source:

    The CAPACITY-COVID Collaborative Consortium and LEOSS Study Group.


    Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.